Rev Neurol (Paris) 2021 Jul 9. Epub 2021 Jul 9.
Univ Rennes, EHESP, REPERES (Pharmacoepidemiology and health services research) - EA 7449, 15, avenue du Professeur Léon Bernard, CS 74312, 35000 Rennes, France; Inserm CIC-P 1414, Rennes University Hospital, Rennes University, 2, rue Henri le Guilloux, 35000 Rennes, France.
Background: Most data regarding the use of disease-modifying therapies (DMTs) in multiple sclerosis (MS) comes from clinical series or regional databases that have a risk of recruitment bias. French health administrative data offers the significant advantage of being extensive in regards to both MS population coverage and DMT prescriptions.
Objectives: To describe patterns of DMTs usage at the level of the entire French population of MS patients from 2010 to 2015. Read More